Bladder Cancer Screening Trial
Launched by UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER · Dec 1, 2022
Trial Information
Current as of January 21, 2025
Recruiting
Keywords
ClinConnect Summary
The Bladder Cancer Screening Trial is studying whether regular urine tests can help detect bladder cancer earlier in people who are at higher risk. Researchers want to find out if testing urine every six months for two years can improve early diagnosis of bladder cancer, which can lead to better treatment outcomes. This trial is currently looking for participants who are at least 50 years old, have a significant history of smoking (15 years of smoking 15 cigarettes a day), or have worked in jobs that expose them to certain chemicals for at least 15 years, such as in textile or painting industries.
Eligible participants will be asked to take a simple urine test every six months for two years. It's important to note that individuals with a history of bladder, kidney, or prostate cancer, or those who have had tests for blood in their urine in the past two years, cannot join the study. Participants will help researchers understand the potential benefits of regular screening for bladder cancer, which currently does not have an accepted screening method. Your involvement could contribute to important findings that may improve bladder cancer detection in the future.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Age ≥ 50
- • Smoking: ≥15 pack-year smoking history
- • Occupation:≥ 15 years of occupational exposures including: textile worker, painter, dry cleaners
- Exclusion Criteria:
- • Prior history of bladder, kidney, or prostate cancer
- • Prior evaluation of micro or gross hematuria within the last 2 years
- • Do not provide informed consent
Trial Officials
Yair Lotan, MD
Principal Investigator
UT Southwestern Medical Center
About University Of Texas Southwestern Medical Center
The University of Texas Southwestern Medical Center is a leading academic medical institution dedicated to advancing healthcare through innovative research, education, and clinical excellence. With a strong emphasis on translational medicine, the center conducts cutting-edge clinical trials aimed at developing novel therapies and improving patient outcomes across a wide range of diseases. Its multidisciplinary approach leverages a collaborative network of renowned faculty, state-of-the-art facilities, and a commitment to ethical research practices, positioning UT Southwestern at the forefront of medical discovery and patient care.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Dallas, Texas, United States
People applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Discussion 0
Similar Trials